EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease

Mingzhuo Zhang iD, Marc Tatar, Rujun Gong iD

Clinical Science · 26.06.2025 · 139 (12) · 605-625

DOI: 10.1042/cs20245219 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 17.06.2025. Verfasst von Mingzhuo Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, U.S.A. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Renal Insufficiency, Chronic, Kidney. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a serious medical condition that poses substantial burdens on patients, families, healthcare systems, and society as a whole. It is characterized by progressive kidney damage and loss of function in the kidney, often compounded by underlying conditions such as diabetes, hypertension, and autoimmune diseases. Glycogen synthase kinase 3 beta (GSK3β), a highly conserved serine/threonine kinase originally implicated in insulin signaling, has emerged as a convergent point of multiple pathways implicated in the pathogenesis and progression of CKD. In the kidney, GSK3β regulates cell fate across diverse cells, including podocytes, mesangial cells, and renal tubular cells, through its interactions with key signaling pathways such as Wnt/β-catenin, NF-κB, Nrf2, PI3K/Akt, and cytoskeleton remodeling pathways. Evidence suggests that dysregulation of GSK3β is closely associated with pathological changes in the kidney, including podocyte injury, mesangial expansion, interstitial fibrosis, and tubular atrophy, which collectively drive chronic kidney destruction. In CKD, GSK3β is overexpressed and thus hyperactive in kidney cells. This sustained hyperactivity perpetuates oxidative stress and profibrotic signaling, particularly in renal tubular cells, thus accelerating the transition from acute kidney injury to CKD. Pharmacological targeting of GSK3β with selective inhibitors has shown promise in preclinical models, by reducing kidney injury, attenuating renal fibrosis, and promoting renal recovery, positioning GSK3β as a potential therapeutic target for CKD. This review highlights recent advances in understanding the molecular and cellular mechanisms through which GSK3β contributes to CKD and underscores its potential as a therapeutic target for various chronic renal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Synthase Kinase 3 betaRenal Insufficiency, ChronicKidneyHumansAnimalsDisease ProgressionSignal Transduction

Stichwörter der Autor:innen

CKDGSK3LithiumOxidative stresspodocytopathy

Substanzen

Glycogen Synthase Kinase 3 betaGSK3B protein, human

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, U.S.A.
  • Department of Ecology, Evolution and Organismal Biology, Brown University, Providence, RI, U.S.A.

ORCID-Profile: Mingzhuo Zhang, Rujun Gong

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS

Zitieren

APA

Zhang, M., Tatar, M., & Gong, R. (2025). Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease. Clinical Science, 139(12), 605-625. https://doi.org/10.1042/cs20245219

Vancouver

Zhang M, Tatar M, Gong R. Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease. Clinical Science. 2025;139(12):605-625. doi:10.1042/cs20245219

BibTeX
@article{Zhang2025,
  author = {Zhang, Mingzhuo and Tatar, Marc and Gong, Rujun},
  title = {Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {12},
  pages = {605--625},
  doi = {10.1042/cs20245219}
}
Kostenlos starten →